WallStreetZenWallStreetZen

NASDAQ: ERNA
Eterna Therapeutics Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Eterna Therapeutics earnings were -$46.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ERNA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$8.2M, up 42.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ERNA reported annual earnings of -$44.6M, with 105.5% growth.

ERNA earnings history

Current Revenue
$535.0k
Current Earnings
-$46.1M
Current Profit Margin
-8,618.7%

ERNA Return on Equity

Current Company
N/A
Current Industry
-60.5%
Current Market
28.6%

ERNA undefined

Current Company
-285.8%
Current Industry
-2%
ERNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ERNA announces earnings.

ERNA undefined

Current Company
745.47%
Current Industry
6.4%
ERNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ERNA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ERNA-$38.93M-$46.11MN/A-$2.18
ABP-$8.18M-$20.25MN/A-$0.69
MEIP-$29.66M-$31.66MN/A-$4.75
UBX-$26.68M-$27.50MN/A-$1.62
EDSA-$5.67M-$5.84MN/A-$1.59
View Top Biotech Stocks

Eterna Therapeutics Earnings Reports & History FAQ

What were Eterna Therapeutics's earnings last quarter?

On ERNA's earnings call on Invalid Date, Eterna Therapeutics (NASDAQ: ERNA) reported Q1 2025 earnings per share (EPS) of -$0.15, up 87.8% year over year. Total ERNA earnings for the quarter were -$8.20 million. In the same quarter last year, Eterna Therapeutics's earnings per share (EPS) was -$1.23.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.

Is Eterna Therapeutics profitable or losing money?

As of the last Eterna Therapeutics earnings report, Eterna Therapeutics is currently losing money. Eterna Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$46.09 million, a 101.29% increase year over year.

What was ERNA's earnings growth in the past year?

As of Eterna Therapeutics's earnings date in Invalid Date, Eterna Therapeutics's earnings has grown year over year. ERNA earnings in the past year totalled -$46.11 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.